- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
MR imaging features to predict the type of bone metastasis in prostate cancer ; volume:13 ; number:1 ; day:18 ; month:7 ; year:2023 ; pages:1-8 ; date:12.2023
Scientific reports ; 13, Heft 1 (18.7.2023), 1-8, 12.2023
- Creator
-
Koyama, Hiroaki
Kurokawa, Ryo
Kato, Shimpei
Ishida, Masanori
Kuroda, Ryohei
Ushiku, Tetsuo
Kume, Haruki
Abe, Osamu
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-38878-0
- URN
-
urn:nbn:de:101:1-2023102413061825437486
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Koyama, Hiroaki
- Kurokawa, Ryo
- Kato, Shimpei
- Ishida, Masanori
- Kuroda, Ryohei
- Ushiku, Tetsuo
- Kume, Haruki
- Abe, Osamu
- SpringerLink (Online service)
Other Objects (12)
Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancer
Outcomes of metastasis-directed therapy of bone oligometastatic prostate cancer
Targeting TUBB3 Suppresses Anoikis Resistance and Bone Metastasis in Prostate Cancer
The role of S100A4 for bone metastasis in prostate cancer cells
Pharmacological targeting of CXCL12/CXCR4 signaling in prostate cancer bone metastasis
Prostate cancer metastasis and soy isoflavones : a dogfight over a bone
Myeloid-like tumor hybrid cells in bone marrow promote progression of prostate cancer bone metastasis
GDF15 propeptide promotes bone metastasis of castration-resistant prostate cancer by augmenting the bone microenvironment
Identifying metabolomic features that predict metastasis of melanoma from a primary site
Clinical features and KRAS mutation in colorectal cancer with bone metastasis
Procoxacin bidirectionally inhibits osteoblastic and osteoclastic activity in bone and suppresses bone metastasis of prostate cancer
Mutant Kras-induced upregulation of CD24 enhances prostate cancer stemness and bone metastasis
Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancer
Outcomes of metastasis-directed therapy of bone oligometastatic prostate cancer
Targeting TUBB3 Suppresses Anoikis Resistance and Bone Metastasis in Prostate Cancer
The role of S100A4 for bone metastasis in prostate cancer cells
Pharmacological targeting of CXCL12/CXCR4 signaling in prostate cancer bone metastasis
Prostate cancer metastasis and soy isoflavones : a dogfight over a bone
Myeloid-like tumor hybrid cells in bone marrow promote progression of prostate cancer bone metastasis
GDF15 propeptide promotes bone metastasis of castration-resistant prostate cancer by augmenting the bone microenvironment
Identifying metabolomic features that predict metastasis of melanoma from a primary site
Clinical features and KRAS mutation in colorectal cancer with bone metastasis
Procoxacin bidirectionally inhibits osteoblastic and osteoclastic activity in bone and suppresses bone metastasis of prostate cancer
Mutant Kras-induced upregulation of CD24 enhances prostate cancer stemness and bone metastasis
Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancer
Outcomes of metastasis-directed therapy of bone oligometastatic prostate cancer
Targeting TUBB3 Suppresses Anoikis Resistance and Bone Metastasis in Prostate Cancer
The role of S100A4 for bone metastasis in prostate cancer cells
Pharmacological targeting of CXCL12/CXCR4 signaling in prostate cancer bone metastasis
Prostate cancer metastasis and soy isoflavones : a dogfight over a bone
Myeloid-like tumor hybrid cells in bone marrow promote progression of prostate cancer bone metastasis
GDF15 propeptide promotes bone metastasis of castration-resistant prostate cancer by augmenting the bone microenvironment
Identifying metabolomic features that predict metastasis of melanoma from a primary site
Clinical features and KRAS mutation in colorectal cancer with bone metastasis
Procoxacin bidirectionally inhibits osteoblastic and osteoclastic activity in bone and suppresses bone metastasis of prostate cancer